120 related articles for article (PubMed ID: 12928480)
1. Allele-specific silencing of a pathogenic mutant acetylcholine receptor subunit by RNA interference.
Abdelgany A; Wood M; Beeson D
Hum Mol Genet; 2003 Oct; 12(20):2637-44. PubMed ID: 12928480
[TBL] [Abstract][Full Text] [Related]
2. Toward therapy for DYT1 dystonia: allele-specific silencing of mutant TorsinA.
Gonzalez-Alegre P; Miller VM; Davidson BL; Paulson HL
Ann Neurol; 2003 Jun; 53(6):781-7. PubMed ID: 12783425
[TBL] [Abstract][Full Text] [Related]
3. Short hairpin RNA and retroviral vector-mediated silencing of p53 in mammalian cells.
Liu XD; Ma SM; Liu Y; Liu SZ; Sehon A
Biochem Biophys Res Commun; 2004 Nov; 324(4):1173-8. PubMed ID: 15504337
[TBL] [Abstract][Full Text] [Related]
4. Nonviral vector-mediated RNA interference: its gene silencing characteristics and important factors to achieve RNAi-based gene therapy.
Takahashi Y; Nishikawa M; Takakura Y
Adv Drug Deliv Rev; 2009 Jul; 61(9):760-6. PubMed ID: 19386274
[TBL] [Abstract][Full Text] [Related]
5. Mutation of the acetylcholine receptor epsilon-subunit promoter in congenital myasthenic syndrome.
Nichols P; Croxen R; Vincent A; Rutter R; Hutchinson M; Newsom-Davis J; Beeson D
Ann Neurol; 1999 Apr; 45(4):439-43. PubMed ID: 10211467
[TBL] [Abstract][Full Text] [Related]
6. A tightly regulated and reversibly inducible siRNA expression system for conditional RNAi-mediated gene silencing in mammalian cells.
Wu RH; Cheng TL; Lo SR; Hsu HC; Hung CF; Teng CF; Wu MP; Tsai WH; Chang WT
J Gene Med; 2007 Jul; 9(7):620-34. PubMed ID: 17486668
[TBL] [Abstract][Full Text] [Related]
7. Allele-specific silencing by RNA interference.
Hohjoh H
Methods Mol Biol; 2010; 623():67-79. PubMed ID: 20217544
[TBL] [Abstract][Full Text] [Related]
8. Vaccinia virus double-stranded RNA-binding protein E3 does not interfere with siRNA-mediated gene silencing in mammalian cells.
Lantermann M; Schwantes A; Sliva K; Sutter G; Schnierle BS
Virus Res; 2007 Jun; 126(1-2):1-8. PubMed ID: 17306404
[TBL] [Abstract][Full Text] [Related]
9. Silencing of human alpha-synuclein in vitro and in rat brain using lentiviral-mediated RNAi.
Sapru MK; Yates JW; Hogan S; Jiang L; Halter J; Bohn MC
Exp Neurol; 2006 Apr; 198(2):382-90. PubMed ID: 16455076
[TBL] [Abstract][Full Text] [Related]
10. Cellular knock-down of quinone reductase 2: a laborious road to successful inhibition by RNA interference.
Chomarat P; Cogé F; Guénin SP; Mailliet F; Vella F; Mallet C; Giraudet S; Nagel N; Leonce S; Ferry G; Delagrange P; Boutin JA
Biochimie; 2007 Oct; 89(10):1264-75. PubMed ID: 17714848
[TBL] [Abstract][Full Text] [Related]
11. Selective silencing of a mutant transthyretin allele by small interfering RNAs.
Kurosawa T; Igarashi S; Nishizawa M; Onodera O
Biochem Biophys Res Commun; 2005 Nov; 337(3):1012-8. PubMed ID: 16225852
[TBL] [Abstract][Full Text] [Related]
12. Regulation of monocyte chemoattractant protein-1 by the oxidized lipid, 13-hydroperoxyoctadecadienoic acid, in vascular smooth muscle cells via nuclear factor-kappa B (NF-kappa B).
Dwarakanath RS; Sahar S; Reddy MA; Castanotto D; Rossi JJ; Natarajan R
J Mol Cell Cardiol; 2004 Apr; 36(4):585-95. PubMed ID: 15081318
[TBL] [Abstract][Full Text] [Related]
13. Transposon-based RNAi delivery system for generating knockdown cell lines.
Heggestad AD; Notterpek L; Fletcher BS
Biochem Biophys Res Commun; 2004 Apr; 316(3):643-50. PubMed ID: 15033448
[TBL] [Abstract][Full Text] [Related]
14. Primer extension-based method for the generation of a siRNA/miRNA expression vector.
Gou D; Zhang H; Baviskar PS; Liu L
Physiol Genomics; 2007 Nov; 31(3):554-62. PubMed ID: 17804605
[TBL] [Abstract][Full Text] [Related]
15. RNAi expression vectors in mammalian cells.
Miyagishi M; Taira K
Methods Mol Biol; 2004; 252():483-91. PubMed ID: 15017073
[TBL] [Abstract][Full Text] [Related]
16. [Specific inhibition of hTERT gene expression by short interfering RNAs in gastric cancer SGC7901 cell].
Ma JP; Zhan WH; Wang JP; Peng JS; Gao JS; Yin QW
Zhonghua Wai Ke Za Zhi; 2004 Nov; 42(22):1372-6. PubMed ID: 15634407
[TBL] [Abstract][Full Text] [Related]
17. End-plate acetylcholine receptor deficiency due to nonsense mutations in the epsilon subunit.
Engel AG; Ohno K; Bouzat C; Sine SM; Griggs RC
Ann Neurol; 1996 Nov; 40(5):810-7. PubMed ID: 8957026
[TBL] [Abstract][Full Text] [Related]
18. Choice of the adequate detection time for the accurate evaluation of the efficiency of siRNA-induced gene silencing.
Choi I; Cho BR; Kim D; Miyagawa S; Kubo T; Kim JY; Park CG; Hwang WS; Lee JS; Ahn C
J Biotechnol; 2005 Nov; 120(3):251-61. PubMed ID: 16095743
[TBL] [Abstract][Full Text] [Related]
19. Silencing of HIV-1 with RNA interference: a multiple shRNA approach.
ter Brake O; Konstantinova P; Ceylan M; Berkhout B
Mol Ther; 2006 Dec; 14(6):883-92. PubMed ID: 16959541
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Bcl-2 expression by a novel tumor-specific RNA interference system increases chemosensitivity to 5-fluorouracil in Hela cells.
Huang SL; Wu Y; Yu H; Zhang P; Zhang XQ; Ying L; Zhao HF
Acta Pharmacol Sin; 2006 Feb; 27(2):242-8. PubMed ID: 16412276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
